KKKI 538
Latest Information Update: 24 May 2001
At a glance
- Originator Hungarian Academy of Sciences
- Developer Feminique Corporation; Hungarian Academy of Sciences
- Class Antisense oligonucleotides; Antivirals
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 24 May 2001 Profile reviewed but no significant changes made
- 14 Jul 1998 No-Development-Reported for HIV infections treatment in Hungary (Unknown route)
- 14 Jul 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)